Sunshine Biopharma (SBFM) Total Debt Growth (1y) (2015 - 2021)
Sunshine Biopharma (SBFM) Total Debt Growth (1y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -13.33% |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 100.21% |
| Sep 30, 2021 | 796.15% |
| Jun 30, 2021 | 3,148.59% |
| Sep 30, 2020 | 1,198.25% |
| Jun 30, 2020 | 126.90% |
| Sep 30, 2019 | -91.19% |
| Mar 31, 2019 | 8.50% |
| Dec 31, 2018 | -47.92% |
| Dec 31, 2017 | 753.00% |
| Dec 31, 2016 | -31.53% |
| Dec 31, 2015 | -78.73% |